Cardiovascular Outcomes Associated With Gonadotropin-Releasing Hormone Antagonists vs GonadotropinReleasing Hormone Agonists for Prostate Cancer Treatment: A MetaAnalysis of Randomized Controlled Trials

被引：0
|
作者：
Jaiswal, Vikash
Jaiswal, Akash
Saleeb, Marina
Jha, Mayank
Hanif, Muhammad
Kalra, Kriti
Evbayekha, Endurance O.
Agrawal, Vibhor
Ang, Song Peng
Zacks, Jerome S.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Cardiovascular Risk; Estrogen; Outcomes; Cardio-oncology;
D O I：
10.1161/circ.148.suppl_1.12107
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A12107
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Gonadotropin-releasing hormone agonists in the treatment of prostate cancer
    Labrie, F
    Bélanger, A
    Luu-The, V
    Labrie, C
    Simard, J
    Cusan, L
    Gomez, J
    Candas, B
    ENDOCRINE REVIEWS, 2005, 26 (03) : 361 - 379
  • [2] Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer
    Kittai, Adam S.
    Blank, Jessica
    Graff, Julie N.
    ONCOLOGY-NEW YORK, 2018, 32 (12): : 599 - 606
  • [3] The cardiovascular effects of gonadotropin-releasing hormone antagonists in men with prostate cancer
    Cirne, Filipe
    Aghel, Nazanin
    Petropoulos, Jo-Anne
    Klotz, Laurence
    Lenihan, Daniel J.
    Saad, Fred
    Pinthus, Jehonathan
    Leong, Darryl P.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (03) : 253 - 262
  • [4] Considerations for the use of gonadotropin-releasing hormone agonists and antagonists in patients with prostate cancer
    Van Poppel, Hendrik
    Abrahamsson, Per-Anders
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (10) : 830 - 837
  • [5] Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist
    Crawford, E. David
    Hafron, Jason M.
    Debruyne, Frans
    Wallis, Christopher
    Chang, Steven
    Garnick, Marc B.
    JOURNAL OF UROLOGY, 2024, 211 (01): : 63 - 70
  • [6] Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone-Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist
    Stira, Jordi
    Gravina, Carmen
    Lombardo, Riccardo
    De Nunzio, Cosimo
    JOURNAL OF UROLOGY, 2024, 211 (03):
  • [7] Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer
    Choi, Seungtaek
    Lee, Andrew K.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2011, 3 : 107 - 119
  • [8] Gonadoliberin (Gonadotropin-Releasing Hormone), Its Agonists and Antagonists
    Holicka, Martina
    Vyslouzil, Jakub
    Kubova, Katerina
    Muselik, Jan
    Vetchy, David
    CHEMICKE LISTY, 2021, 115 (10): : 516 - 523
  • [9] Current and emerging gonadotropin-releasing hormone (GnRH) antagonists for the treatment of prostate cancer
    Moussa, Mohamad
    Papatsoris, Athanasios
    Dellis, Athanasios
    Abou Chakra, Mohamed
    Fragkoulis, Charalampos
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (17) : 2373 - 2381
  • [10] A prospective randomized study comparing gonadotropin-releasing hormone agonists or gonadotropin-releasing hormone antagonists in couples with unexplained infertility and/or mild oligozoospermia
    Zikopoulos, K
    Kaponis, A
    Adonakis, G
    Sotiriadis, A
    Kalantaridou, S
    Georgiou, I
    Paraskevaidis, E
    FERTILITY AND STERILITY, 2005, 83 (05) : 1354 - 1362
12345